10X GENOMICS INC-CLASS A (TXG) Stock Earnings Estimates
NASDAQ:TXG • US88025U1097
19.19 USD
-0.38 (-1.94%)
At close: Feb 19, 2026
19.1 USD
-0.09 (-0.47%)
After Hours: 2/19/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 618.727M 19.82% | 610.785M -1.28% | 642.823M 5.25% | 619.88M -3.57% | 665.27M 7.32% | 720.77M 8.34% | 778.26M 7.98% | 838.75M 7.77% | 978.79M 16.70% | 1.246B 27.30% | |
| EBITDA YoY % growth | -159.437M -11.86% | -156.58M 1.79% | N/A 72.52% | -84.534M -96.48% | -74.748M 11.58% | -38.38M 48.65% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -194.949M -16.11% | -192.459M 1.28% | -110.885M 42.39% | -87.637M 20.97% | -94.691M -8.05% | -80.504M 14.98% | -76.76M 4.65% | -49.44M 35.59% | 23.735M 148.01% | 59.186M 149.36% | |
| Operating Margin | -31.51% | -31.51% | -17.25% | -14.14% | -14.23% | -11.17% | -9.86% | -5.89% | 2.42% | 4.75% | |
| EPS YoY % growth | -2.17 -47.62% | -1.52 29.95% | -0.43 71.71% | -0.96 -122.99% | -0.71 25.60% | 0.00 100.00% | 0.30 | 0.61 100.00% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 17.01% | -0.24 -186.70% | -0.23 -3.39% | -0.20 -53.41% | -0.26 13.80% | -0.19 23.03% | -0.19 16.74% | -0.12 41.76% | -0.33 -29.41% | -0.11 40.54% | -0.10 46.67% |
| Revenue Q2Q % growth | 148.07M -4.40% | 151.46M -12.40% | 156.58M 5.09% | 164.17M -1.12% | 153.43M 3.62% | 160.01M 5.65% | 165.15M 5.47% | 177.43M 8.08% | 167.96M 9.47% | 176.35M 10.21% | 180.69M 9.41% |
| EBITDA Q2Q % growth | -34.515M 14.79% | -22.138M -296.55% | -23.333M -331.46% | -18.424M 16.49% | -19.453M 43.64% | -20.013M 9.60% | -27.103M -16.16% | -9.842M 46.58% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -40.723M 16.08% | -33.646M -635.59% | -32.446M -2.87% | -27.376M -40.09% | -33.441M 17.88% | -24.014M 28.63% | -30.071M 7.32% | -23.58M 13.86% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -0.13 67.50% | -0.21 | 0.08 | 39.41% |
| Q3 2025 Q2Q % growth | -0.22 26.67% | -0.29 | 0.07 | 24.40% |
| Q2 2025 Q2Q % growth | 0.28 187.50% | -0.38 | 0.66 | 174.61% |
| Q1 2025 Q2Q % growth | -0.36 28.00% | -0.48 | 0.12 | 24.36% |
| Q4 2024 Q2Q % growth | -0.40 2.44% | -0.30 | -0.10 | -34.43% |
| Q3 2024 Q2Q % growth | -0.30 62.03% | -0.35 | 0.05 | 13.04% |
| Q2 2024 Q2Q % growth | -0.32 39.62% | -0.48 | 0.16 | 33.83% |
| Q1 2024 Q2Q % growth | -0.50 -13.64% | -0.51 | 0.01 | 1.07% |
| Q4 2023 Q2Q % growth | -0.41 -173.33% | -0.36 | -0.05 | -13.26% |
| Q3 2023 Q2Q % growth | -0.79 -113.51% | -0.46 | -0.33 | -70.21% |
| Q2 2023 Q2Q % growth | -0.53 7.02% | -0.41 | -0.12 | -30.01% |
| Q1 2023 Q2Q % growth | -0.44 -15.79% | -0.38 | -0.06 | -16.54% |
| Q4 2022 Q2Q % growth | -0.15 6.25% | -0.31 | 0.16 | 52.34% |
| Q3 2022 Q2Q % growth | -0.37 -146.67% | -0.47 | 0.10 | 21.05% |
| Q2 2022 Q2Q % growth | -0.57 -470.00% | -0.39 | -0.18 | -45.45% |
| Q1 2022 Q2Q % growth | -0.38 -245.45% | -0.32 | -0.06 | -20.32% |
| Q4 2021 Q2Q % growth | -0.16 95.87% | -0.09 | -0.07 | -83.39% |
| Q3 2021 Q2Q % growth | -0.15 76.92% | -0.20 | 0.05 | 26.60% |
| Q2 2021 Q2Q % growth | -0.10 75.61% | -0.26 | 0.16 | 61.95% |
| Q1 2021 Q2Q % growth | -0.11 45.00% | -0.28 | 0.17 | 60.14% |
| Q4 2020 Q2Q % growth | -3.87 | -0.23 | -3.64 | -1,584.26% |
| Q3 2020 Q2Q % growth | -0.65 | -0.31 | -0.34 | -110.91% |
| Q2 2020 Q2Q % growth | -0.41 | -0.56 | 0.15 | 26.55% |
| Q1 2020 Q2Q % growth | -0.20 | -0.13 | -0.07 | -49.34% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 166.03M 0.61% | 160.87M | 5.16M | 3.21% |
| Q3 2025 Q2Q % growth | 149.002M -1.75% | 143.91M | 5.092M | 3.54% |
| Q2 2025 Q2Q % growth | 172.908M 12.93% | 140.83M | 32.078M | 22.78% |
| Q1 2025 Q2Q % growth | 154.883M 9.84% | 133.78M | 21.103M | 15.77% |
| Q4 2024 Q2Q % growth | 165.021M -10.30% | 160.98M | 4.041M | 2.51% |
| Q3 2024 Q2Q % growth | 151.654M -1.30% | 160.22M | -8.566M | -5.35% |
| Q2 2024 Q2Q % growth | 153.104M 4.28% | 151.59M | 1.514M | 1.00% |
| Q1 2024 Q2Q % growth | 141.006M 5.01% | 143.67M | -2.664M | -1.85% |
| Q4 2023 Q2Q % growth | 183.979M 17.78% | 184.63M | -651K | -0.35% |
| Q3 2023 Q2Q % growth | 153.644M 17.20% | 152.78M | 864K | 0.57% |
| Q2 2023 Q2Q % growth | 146.819M 28.11% | 141.36M | 5.459M | 3.86% |
| Q1 2023 Q2Q % growth | 134.285M 17.28% | 130.11M | 4.175M | 3.21% |
| Q4 2022 Q2Q % growth | 156.2M 8.85% | 149.65M | 6.55M | 4.38% |
| Q3 2022 Q2Q % growth | 131.1M 4.63% | 130.87M | 230K | 0.18% |
| Q2 2022 Q2Q % growth | 114.6M -1.04% | 118.37M | -3.77M | -3.18% |
| Q1 2022 Q2Q % growth | 114.5M 8.22% | 114.48M | 20K | 0.02% |
| Q4 2021 Q2Q % growth | 143.5M 27.90% | 150.02M | -6.52M | -4.35% |
| Q3 2021 Q2Q % growth | 125.3M 74.51% | 123.84M | 1.46M | 1.18% |
| Q2 2021 Q2Q % growth | 115.8M 169.93% | 113.98M | 1.82M | 1.60% |
| Q1 2021 Q2Q % growth | 105.8M 47.15% | 103.53M | 2.27M | 2.19% |
| Q4 2020 Q2Q % growth | 112.2M | 101.41M | 10.79M | 10.64% |
| Q3 2020 Q2Q % growth | 71.8M | 61.838M | 9.962M | 16.11% |
| Q2 2020 Q2Q % growth | 42.9M | 29.856M | 13.044M | 43.69% |
| Q1 2020 Q2Q % growth | 71.9M | 74.159M | -2.259M | -3.05% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.15% | 13.49% | 13.8% | 30.14% |
| Revenue | 0.96% | 3.34% | 0.23% | 3.02% |